Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor

Area of Science:

• Molecular Biology
• Pharmacology
• Drug Discovery

Background:

• Retinoid X receptors (RXRs) are crucial nuclear receptors with significant roles in gene transcription and non-genomic activities.
• Their involvement in physiological and pathophysiological processes makes RXRs important therapeutic targets for cancer, metabolic, and neurodegenerative diseases.

Purpose of the Study:

• To review recent advancements in the design and discovery of Retinoid X receptor (RXR) modulators.
• To highlight modulators that target novel binding sites on RXR, moving beyond the canonical ligand-binding pocket.

Main Methods:

• Literature review of recent studies on RXR modulator development.
• Analysis of small molecules interacting with RXR through both traditional and novel binding mechanisms.

Main Results:

• RXRs are central transcriptional factors with diverse biological activities, making them valuable drug targets.
• Small molecule modulators of RXR are being developed as therapeutic agents and research tools.
• Emerging research indicates that small molecules can modulate RXR activity by binding to sites other than the canonical ligand-binding pocket.

Conclusions:

• The development of RXR modulators targeting novel binding sites represents a promising frontier in drug discovery.
• Exploring these new mechanisms can lead to more effective and selective therapeutic strategies for a range of diseases.